Table 2 Clinical baseline characteristics of the patients in the high- and low-risk groups (CD158a)
Baseline characteristics | High-risk group (n = 26) | Low-risk group (n = 25) | P |
|---|---|---|---|
Sex (male: female) | 23:3 | 19:6 | 0.060 |
Age (years) | 61 (46–77) | 62 (37–83) | 0.850 |
Child–Pugh (5:6) | 24:2 | 23:2 | 0.631 |
TBIL (µmol/L) | 18.7 (6.1–48.2) | 17.3 (10.4–37.1) | 0.523 |
AIB (g/L) | 39.5 (33.6–47.6) | 40 (32.9–48.7) | 0.568 |
PLT (× 109/L) | 145 (55–316) | 137 (61–232) | 0.668 |
PTA (%) | 83.5 (67–95) | 86 (69–108) | 0.213 |
Etiology (HBV) | HBV (100%) | HBV (100%) |  > 0.999 |
Diameter of HCC (mm) | 25.9 (9–40) | 20 (9–39) | 0.019 |
AFP (ng/ml) | 88.7 (1.39–1096) | 773.6 (1.69–17,694) | 0.328 |
BCLC staging | A (100%) | A (100%) |  > 0.999 |
HBV-DNA (copies/ml) | 117.7 (10–2040) | 372.3 (10–8015) | 0.433 |